QUANTUM X LABS INC. current report, 12 March 2025

Business Context and Reporting Period

This Form 8-K is filed by Viewbix Inc. (noted as Quantum X Labs Inc. in metadata) for the reporting date of March 12, 2025. The filing addresses Item 8.01 (Other Events) regarding the regulatory approval and implementation of a previously announced 1-for-4 reverse stock split of the Company's common stock.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure adjustments.

  • Pre-Split Outstanding Shares: 21,179,686
  • Post-Split Outstanding Shares: Approximately 5,294,922
  • Authorized Shares: 490,000,000 (unchanged)
  • Par Value: $0.0001 per share (unchanged)
  • New CUSIP: 926711300

Material Changes

The primary material change is the reduction of outstanding common stock by a ratio of 1-for-4, effective March 14, 2025. Key operational changes include:

  • Trading Symbol: The ticker will temporarily change to "VBIXD" for 20 trading days to indicate the split, reverting to "VBIX" thereafter.
  • Fractional Shares: No fractional shares will be issued; any resulting fractions will be rounded up to the nearest whole share.
  • Derivatives Adjustment: Outstanding warrants, options, and convertible securities will have their share counts and exercise/conversion prices ratably adjusted.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of new risks or contingencies beyond the mechanics of the stock split. The event is a procedural execution of a plan disclosed in a prior filing on July 19, 2024.

Investor Verification Checklist

  • Verify the effective date of the reverse stock split (March 14, 2025) and the temporary ticker symbol "VBIXD" on the OTC Pink Marketplace.
  • Confirm the new CUSIP number (926711300) for post-split trading.
  • Review the terms of any held warrants or options to ensure exercise prices and share quantities have been correctly adjusted by the 1-for-4 ratio.
  • Check brokerage statements for the rounding up of any fractional shares resulting from the split.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.